Virginia Board of Medicine Practitioner Information

Home Icon Home

Search Icon Search

Disclaimer Icon Disclaimers

Links Icon Links

Glossary Icon Glossary

Help Icon Questions


Printer Friendly Version Printer Icon
 

Gaurav Nayyar, MD

 LICENSE # 0101266684
 
Issue Date: 4/17/2019
Expiration Date: 1/31/2026
Status: Current Active


General InformationEducationCertifications & Practice AreaInsuranceHonors & AwardsAcademic Appointments & PublicationsProceedings, Actions & ConvictionsPaid Claims
Unless otherwise indicated, this information has been self-reported and has not been verified by the Board of Medicine.


Academic Appointments
Last Updated 6/2/2019
None Reported
Academic Appointments - Non-US
Last Updated 6/2/2019
None Reported
Publications
(up to ten in the last five years)
Last Updated 12/21/2021
Overcoming Resistance to Natural Killer Cell Based Immunotherapies for Solid Tumors
Frontiers in Oncology
Volume 9 Issue 51
Date: 02 2019
https://www.frontiersin.org/articles/10.3389/fonc.2019.00051/full

Novel cytokine-antibody fusion protein, N-820, to enhance the functions of ex vivo expanded natural killer cells against Burkitt lymphoma
J Immunother Cancer
Vol 8 Issue 2
Date: 10 2020
https://jitc.bmj.com/content/8/2/e001238.long

Combinatorial immunotherapy of N-803 (IL-15 superagonist) and dinutuximab with ex vivo expanded natural killer cells significantly enhances in vitro cytotoxicity against GD2 + pediatric solid tumors and in vivo survival of xenografted immunodeficient NSG
J Immunother Cancer
9, Issue 7
Date: 07 2021
https://jitc.bmj.com/content/9/7/e002267.long